A number of growth factors have been implicated in the development and perpetuation of preretinal fibrovascular membranes in patients with proliferative diabetic retinopathy (PDR). The aim of this study was to determine the potential role of epidermal growth factor (EGF), transforming growth factor alpha (TGF-a), and their receptor (EGF-R) in PDR development. Immunostaining for EGF, TGF-a, and EGF-R was compared between normal retina, PDR retina, and PDR preretinal membranes. Weak staining for EGF and EGF-R was observed throughout the neural retina from non-diabetic eyes while weak to moderate staining for TGF-a was observed in the ganglion cell layer and the inner and outer nuclear layers. In contrast, intense staining for EGF and TGF-a and moderate staining for EGF-R were observed throughout the PDR retina. Immunoreactivity for EGF, TGF-a, and EGF-R was seen in the majority of the 11 excised membranes studied and, though variable, was generally greater than that observed in normal retinas. These results suggest an autocrine/paracrine role for EGF, TGF-a, and EGF-R in PDR. (BrJ Ophthalmol 1994; 78: 
Proliferative diabetic retinopathy (PDR) is characterised by preretinal neovascularisation and fibrosis ultimately leading to vitreous haemorrhage and traction retinal detachment. It is likely that growth factors (which are known to modulate cell proliferation, cell migration, and the production of proteolytic enzymes, collagen, and other extracellular matrix molecules) are involved in the various steps of this disease process.
I Support for growth factor involvement comes from the analysis of vitreous gel specimens which demonstrate increased levels of a variety of growth factors in PDR compared with gel removed from eyes not undergoing a proliferative response. [2] [3] [4] [5] However, it is uncertain whether these growth factors originate from within the pathological tissue mass and thus act in a paracrine/autocrine fashion or whether they are derived from some other source (that is, systemically or from other cells/tissues within the eye such as the retina).
The aim of this study was to determine the potential role in PDR of one growth factor family -namely epidermal growth factor (EGF) and transforming growth factor alpha (TGF-a), which have a 40% homology and which act through the same receptor. ' 4 ,um thick, of the wax embedded specimens were dewaxed in xylene and rehydrated through a series of graded alcohols. The sections were washed in TBS and incubated with 0-1% chymotrypsin in TBS for 20 minutes at 37°C. The sections were washed in TBS and incubated in normal goat serum (Sigma) for 10 minutes to block non-specific binding. Excess serum was removed by washing in TBS and the primary antibody was applied for 1 hour at room temperature. Following three 10 minute washes in TBS, samples were exposed to an anti-mouse/ rabbit IgG conjugated to biotin for 1 hour at room temperature. The sections were washed three times for 10 minutes each in TBS and then incubated with an avidin-biotin alkaline phosphatase reaction complex (Dako). Following extensive washing, antibody binding was visualised using a naphthol phosphate/fast red substrate mixture which resulted in the formation of a red product (endogenous alkaline phosphatase activity was blocked using levamisole at this stage). In some instances immunostained sections were counterstained with haematoxylin to enhance examination. Selected non-immunostained sections were stained with haematoxylin and eosin to permit evaluation of the overall morphology of the specimens.
Negative controls included (1) omission of the primary antibody, and (2) substitution of the primary antibody with an affinity purified mouse IgG at the same concentration as the primary antibody.
Assessment ofimmunostaining
The degree and pattern of immunostaining both within and between specimens was assessed by standard light microscopy. The intensity of staining was graded qualitatively as background, minimal, moderate, or intense; background staining was the level of staining seen in the negative controls, 'intense' corresponding to the highest level of immunoreactivity observed in the positive controls.
Results

CONTROLS
Immunoreactivity for EGF, TGF-a, and EGF-R was seen in the epidermal layer of normal human skin. The non-neural, non-vascular components of the optic nerve exhibited GFAP immunoreactivity. The immunostaining was abolished in sections processed with omission or substitution of the primary antibody (Fig 1F) . NORMAL 
RETINA
Immunostaining for EGF, TGF-a, and EGF-R was observed in the majority of the retinas examined (Fig IA, B ; Table 1 ). EGF demonstrated weak to moderate diffuse staining throughout the neural retina (7/11) and within the RPE (5/11). TGF-a demonstrated weak to moderate staining throughout the neural retina in 10/11 eyes. Staining intensity was greatest in the ganglion cell layer, inner nuclear layer, and outer nuclear layer. Isolated cells within the inner nuclear layer exhibited the highest intensity of staining (Fig iB) . Immunolocalisation of TGF-a was not observed in either the RPE or the choroid. Weak to moderate staining for EGF-R staining was observed throughout the neural retina and RPE in 8/11 of the eyes examined. Some intracellular staining was observed for both peptide growth factors. GFAP staining in the neural retina varied between specimens; 1/11 exhibited no staining, 7/11 very weak staining, and 3/11 intense staining. Staining was either in the peripheral retina (adjacent to microcystoid changes) or in the inner retinal layers (astrocytic staining). There was no correlation between staining pattern/intensity for the antibodies used and either donor age or postmortem time.
PDR RETINA
The retinal fragments consisted of detached full thickness neuroretinal tissue (three eyes) or neuroretina plus RPE (one eye). All of the sensory retinal pieces showed variable gliosis and intense GFAP immunolabelling.
Intense immunoreactivity for EGF and TGF-a was observed throughout all of the excised retinal fragments (Fig 1C, D; Table 1 ). Retinal andpreretinal localisation ofepidermal growthfactor, transforminggrowth factor alpha, and their receptor in proliferative diabetic retinopathy membranes to permit immunostaining for GFAP in nine specimens, EGF in 10 specimens, TGF-a in nine specimens, and EGF-R in 10 specimens.
All of the 11 preretinal membranes were fibrovascular in nature and the fibrous component of the membranes contained isolated cells which were usually fibroblast-like or inflammatory cells. Nevertheless, there was considerable variation within and between membranes in the number and distribution of cells.
Immunoreactivity for EGF, TGF-a, and EGF-R was seen in 9/10, 7/9, and 9/10 of the membranes respectively (Fig IG, H; Table 1 ). The intensity of the immunostaining for each of the peptides varied markedly between and within specimens. Intense immunostaining was seen in six specimens for EGF, four specimens for TGF-a, and two specimens for EGF-R. In general the fibrous component of the membranes exhibited much weaker immunoreactivity for EGF, TGF-a, and EGF-R than cellular areas. As with retinal specimens, variable intracellular EGF, TGF-a, and EGF-R immunostaining was observed in the PDR membranes.
Specific cell types
Vascular endothelial cells were identified in all membranes by factor VIII staining ( Table 2) . The endothelial cells exhibited EGF immunoreactivity in 7/10 specimens, in four of which the staining was intense (Table 1) . TGF-a immunoreactive endothelium was seen in 7/9 specimens, in four of which the immunostaining was intense. EGF-R was found in endothelial cells in 9/10 specimens (one showing intense, four moderate, and four weak staining).
Isolated cells in fibrous tissue showed immunolabelling for EGF in 6/10 specimens (three intensely and one moderately) and TGF-ca in 2/9 (one intensely). EGF-R immunoreactivity was observed on isolated cells in 7/10 membranes, in three of which the staining was moderate.
Variable GFAP staining was observed in 7/11 specimens (aggregates of glial cells in six and isolated glial cells in one) ( Table 2 ). Three glial cell aggregates showed intense (two membranes) or moderate (one membrane) immunostaining for EGF while TGF-a labelling was observed in two (one intense; one weak) preretinal glial cell aggregates. Weak (two specimens) or moderate (one specimen) EGF-R staining was found in three glial clusters.
Discussion
Our results demonstrate weak to moderate immunoreactivity for EGF, TGF-ca, and EGF-R in the majority of normal human adult retinas. Lack of immunostaining in a few retinas may reflect variation between individuals, variation within the staining procedure, or both. This is the first demonstration of the presence of EGF and TGF-a together with their receptor in the human retina in situ. These findings are supported by previous studies on other species. Steady state levels of TGF-ct mRNA have been reported for bovine retinas'0 and the EGF receptor has been localised to cultured human RPE"I and rat Mueller cells. '2 Interestingly, levels of staining intensity for both peptide growth factors and their receptor were increased in full thickness neuroretinal specimens associated with PDR membranes. Furthermore, the immunoreactivity for peptides/receptors was more intense in PDR membranes than the normal retinas. It was difficult to make subjective comparisons between the immunoreactivity in PDR retinal fragments and their associated epiretinal membranes. However, focal staining in the membranes was generally equivalent to that in the PDR retina. The weak diffuse staining observed in the fibrous component of the PDR membranes may reflect peptide growth factor binding to extracellular matrix components, but the staining was considerably less than that previously reported for EGF.
"
The role of these growth factors and their receptor in PRM pathobiology is unclear. PDR membrane formation involves cellular migration and proliferation together with extracellular matrix synthesis.' Such cellular events are likely to be modulated by a variety of growth factors. Two such, EGF and TGF-a, are known to be potent mitogens as well as modulating cell migration, cell differentiation, extracellular matrix synthesis/turnover, receptor transmodulation, and synthesis of other growth factors.8 Given that the receptor for these two peptides is present in PDR membranes it is reasonable to speculate that they are involved in the development and perpetuation of the preretinal tissue.
The origin of these growth factors remains uncertain. Such factors could be of systemic origin or be derived locally from the retina or from within the membranes themselves. It is possible that several different origins are involved. However, the observed intracellular staining within many ofthe cells in both the PDR retinal fragments and preretinal membranes infers local synthesis and the possible existence of an autocrine/paracrine control. This staining for EGF and TGF-a is unlikely to be due to internalisation of the growth factors since EGF receptor complexes undergo rapid internalisation via the endosome system resulting in rapid degradation of both the ligand and the receptor within lysosomal compartments. ' 
